MD-39-AM
MD-39-AM exhibits antihypertensive, diuretic and saliuretic activities with good in vivo pharmacokinetic characters[1][2].
Product Specifications
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/md-39-am.html
Solubility
10 mM in DMSO
Smiles
CSC1=NC(NC2=CC=CC=C2)=C(C=CC=N3)C3=N1
Molecular Formula
C14H12N4S
Molecular Weight
268.34
References & Citations
[1]Monge A, et al., Diuretic and hypotensive activities of 4-anilino derivatives of 2-methylthiopyrido [2, 3-d] pyrimidines[J]. Arzneimittel-forschung, 1990, 40 (11) : 1230-1233.|[2]Pérez MJ, et al., Preliminary pharmacokinetics of a new pyridopyrimidine derivative. Arzneimittelforschung. 1991 Jun;41 (6) :640-4.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-19367/MD-39-AM-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19367/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[72564-74-0]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6387646-01 0.1 mL
NT5C (5'(3')-deoxyribonucleotidase, Cytosolic Type, Cytosolic 5',3'-pyrimidine Nucleotidase, Deoxy-5'-nucleotidase 1, dNT-1, DNT1, UMPH2, DNT, DNT-1, P5N2, PN-I, PN-II) APC
Ask
View Details 
MBS6387646-02 5x 0.1 mL
NT5C (5'(3')-deoxyribonucleotidase, Cytosolic Type, Cytosolic 5',3'-pyrimidine Nucleotidase, Deoxy-5'-nucleotidase 1, dNT-1, DNT1, UMPH2, DNT, DNT-1, P5N2, PN-I, PN-II) APC
Ask
View Details GTR15277372 1 Vial
Lentiviral mouse Fhl4 shRNA (UAS) - Lentiviral mouse Fhl4 shRNA (UAS, iRFP) plasmid
Ask
View Details 